Literature DB >> 25175317

Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.

Giorgio Treglia1, Ramin Sadeghi2, Luca Giovanella1, Stefano Cafarotti3, Pierluigi Filosso4, Filippo Lococo5.   

Abstract

AIM: To perform a systematic review and meta-analysis of published data on the role of fluorine-18-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) in predicting the WHO grade of malignancy in thymic epithelial tumors (TETs).
METHODS: A comprehensive literature search of studies published up to March 2014 was performed. Data on maximum standardized uptake value (SUVmax) in patients with low-risk thymomas (A, AB, B1), high-risk thymomas (B2, B3) and thymic carcinomas (C) according to the WHO classification were collected when reported by the retrieved articles. The comparison of mean SUVmax between low-risk thymomas, high-risk thymomas and thymic carcinomas was expressed as weighted mean difference (WMD) and a pooled WMD was calculated including 95% confidence interval (95%CI).
RESULTS: Eleven studies were selected for the meta-analysis. The pooled WMD of SUVmax between high-risk and low-risk thymomas was 1.2 (95%CI: 0.4-2.0). The pooled WMD of SUVmax between thymic carcinomas and low-risk thymomas was 4.8 (95%CI: 3.4-6.1). Finally, the pooled WMD of SUVmax between thymic carcinomas and high-risk thymomas was 3.5 (95%CI: 2.7-4.3).
CONCLUSIONS: (18)F-FDG PET may predict the WHO grade of malignancy in TETs. In particular, we demonstrated a statistically significant difference of SUVmax between the different TETs (low-grade thymomas, high-grade thymomas and thymic carcinomas).
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  FDG; Meta-analysis; PET/CT; Positron emission tomography; Thymic; Thymoma

Mesh:

Substances:

Year:  2014        PMID: 25175317     DOI: 10.1016/j.lungcan.2014.08.008

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  19 in total

1.  The Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors.

Authors:  Koichi Fukumoto; Takayuki Fukui; Toshiki Okasaka; Koji Kawaguchi; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Tomoshi Sugiyama; Katsuhiko Kato; Kohei Yokoi
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

2.  Texture analysis of 18F-FDG PET/CT for grading thymic epithelial tumours: usefulness of combining SUV and texture parameters.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Tetsuya Shinaji; Masayuki Nakajo; Masaya Aoki; Atsushi Tani; Masami Sato; Takashi Yoshiura
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

3.  Pretreatment biopsy for thymic epithelial tumors-does histology subtype matter for treatment strategy?

Authors:  Sukhmani K Padda; Marlies Keijzers; Heather A Wakelee
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

4.  Application values of 99mTc-methoxyisobutylisonitrile imaging for differentiating benign and malignant thymic masses.

Authors:  Chenghui Lu; Xufu Wang; Bin Liu; Xinfeng Liu; Guoming Wang; Qin Zhang
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

5.  Positron Emission Tomography in Thymic Tumors: Analysis Using a Prospective Research Database.

Authors:  Robert J Korst; Sumudinie Fernando; Ann Christine Catlin; John R Rutledge; Nicolas Girard; James Huang; Frank Detterbeck
Journal:  Ann Thorac Surg       Date:  2017-10-21       Impact factor: 4.330

6.  Usefulness of positron-emission tomography for predicting the World Health Organization grade of thymic epithelial tumors.

Authors:  Takashi Kanou; Soichiro Funaki; Masato Minami; Naoko Ose; Toru Kimura; Eriko Fukui; Tadashi Watabe; Yasushi Shintani
Journal:  Thorac Cancer       Date:  2022-04-22       Impact factor: 3.223

Review 7.  Occasional detection of thymic epithelial tumor 4 years after diagnosis of adult onset Still disease: A challenging case report and immuno-oncological considerations coming from pertinent literature review.

Authors:  Filippo Lococo; Gianluigi Bajocchi; Andrea Caruso; Riccardo Valli; Tommaso Ricchetti; Giorgio Sgarbi; Carlo Salvarani
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (18FDG) positron emission tomography (PET)-CT for evaluation of malignancy in anterior mediastinal lesions: the DECiMaL study.

Authors:  Chiara Proli; Paulo De Sousa; Simon Jordan; Vladimir Anikin; Anand Devaraj; Susannah M Love; Michael Shackcloth; Nikolaos Kostoulas; Kostas Papagiannopoulos; Yama Haqzad; Mahmoud Loubani; Francesco Sellitri; Felice Granato; Alexander Bush; Adrian Marchbank; Swetha Iyer; Marco Scarci; Eric Lim
Journal:  BMJ Open       Date:  2018-02-06       Impact factor: 2.692

9.  Optimal management of thymic malignancies: current perspectives.

Authors:  Gabrielle Drevet; Stéphane Collaud; François Tronc; Nicolas Girard; Jean-Michel Maury
Journal:  Cancer Manag Res       Date:  2019-07-22       Impact factor: 3.989

10.  Quantitative analysis of metabolic parameters at 18F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors.

Authors:  Toshiki Yajima; Akira Mogi; Kimihiro Shimizu; Takayuki Kosaka; Yoichi Ohtaki; Kai Obayashi; Seshiru Nakazawa; Takahito Nakajima; Yoshito Tsushima; Ken Shirabe
Journal:  Oncol Lett       Date:  2020-01-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.